Among patients with recurrence, C1 subtype had marginally significant lower distant recurrence rate (4/23, 17% vs. 19/48, 40%; OR: 0.3, 95% CI: 0.1 – 1.1) and higher local recurrence rate (19/23, 83% vs. 29/48, 60%; OR: 3.1, 95% CI: 0.9 – 10.6) as compared with C2 subtype (Chi-squared test, P = 0.1).
← all excerpts
Transcriptomic Analysis Identified Two Subtypes of Brain Tumor Characterized by Distinct Immune Infiltration and Prognosis.
1
—
—